Financials Arq, Inc.

Equities

ARQ

US00770C1018

Commodity Chemicals

Market Closed - Nasdaq 04:00:00 2024-05-24 pm EDT 5-day change 1st Jan Change
7.17 USD +3.02% Intraday chart for Arq, Inc. -2.45% 0.00%

Valuation

Fiscal Period: December 2023 2024 2025 2026
Capitalization 1 98.88 243 - -
Enterprise Value (EV) 1 98.88 243 243 243
P/E ratio -7.1 x -71.7 x 28.7 x 17.1 x
Yield - - - -
Capitalization / Revenue 1 x 2.39 x 1.7 x 1.54 x
EV / Revenue 1 x 2.39 x 1.7 x 1.54 x
EV / EBITDA -37.9 x 56.5 x 10.3 x 7.5 x
EV / FCF - - - -
FCF Yield - - - -
Price to Book - - - -
Nbr of stocks (in thousands) 33,181 33,897 - -
Reference price 2 2.980 7.170 7.170 7.170
Announcement Date 3/12/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 103 99.18 101.9 143.1 157.5
EBITDA 1 1.274 -2.609 4.3 23.7 32.4
EBIT 1 -12.07 -13.34 -2.7 13.7 22.4
Operating Margin -11.72% -13.44% -2.65% 9.57% 14.22%
Earnings before Tax (EBT) 1 -8.708 -12.1 -2.2 13.7 22.4
Net income 1 -8.917 -12.25 -3.8 9.7 16.5
Net margin -8.66% -12.35% -3.73% 6.78% 10.48%
EPS 2 -0.4800 -0.4200 -0.1000 0.2500 0.4200
Free Cash Flow - - - - -
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 3/8/23 3/12/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - 23.41 20.8 20.44 29.83 28.1 21.74 20.6 30.6 28.9
EBITDA 1 - -1.245 -7.683 -2.993 0.887 7.179 -1.144 -0.8 3.6 2.6
EBIT 1 - -3.374 -7.827 -6.087 -2.525 3.104 -2.98 -2.5 1.9 0.9
Operating Margin - -14.41% -37.62% -29.77% -8.46% 11.04% -13.71% -12.14% 6.21% 3.11%
Earnings before Tax (EBT) 1 - -2.958 -7.541 -5.856 -2.175 3.476 -3.419 -2.8 1.5 0.5
Net income 1 -2.391 -3.167 -7.508 -5.856 -2.175 3.29 -3.419 -2 1.2 0.4
Net margin - -13.53% -36.09% -28.64% -7.29% 11.71% -15.73% -9.71% 3.92% 1.38%
EPS 2 -0.1300 -0.1700 -0.3200 -0.2100 -0.0700 0.1400 -0.0900 -0.0500 0.0300 0.0100
Dividend per Share - - - - - - - - - -
Announcement Date 11/8/22 3/8/23 5/9/23 8/9/23 11/8/23 3/12/24 5/8/24 - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - - - - -
ROE (net income / shareholders' equity) - - - - -
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share - - - - -
Cash Flow per Share - - - - -
Capex 8.91 - - - -
Capex / Sales 8.66% - - - -
Announcement Date 3/8/23 3/12/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
7.17 USD
Average target price
10 USD
Spread / Average Target
+39.47%
Consensus